跳至主要内容
临床试验/NCT03305393
NCT03305393终止不适用

Implementation of a Protocol Utilizing Adaptive CRT in a Normal AV Conduction, CRT Non-Response Population at Generator Replacement

Stern Cardiovascular Foundation, Inc.2 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2017年6月11日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
1
试验地点
2
主要终点
Ejection fraction

研究概览

简要总结

IMPROVE RESPONSE is a physician initiated research study. It is a prospective, non-randomized, multi-center, post-market, U.S. Cardiac Resynchronization Therapy (CRT) in heart failure (HF) observational study. The purpose of this clinical study is to test the hypothesis that market-released CRT devices, which contain the AdaptivCRT (aCRT) algorithm have an incremental benefit in improving CRT response in a chronic CRT non responder population with left bundle branch block (LBBB) and normal atrio-ventricular (AV) condition compared to CRT devices with traditional biventricular pacing delivery methods at generator replacement.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Normal AV conduction (SAV<220 ms or PAV<270 MS)
  • Left Bundle Branch Block (defined as > or = to 140 ms (male) or > or = 130 (female), QR or rS in leads V1 and V2, and Mid QRS notching or slurring in v 2 of leads V1, V2, V5, V6 and I and aVL.)
  • Patient and/or physician assessment or unchanged or worsened heart failure status at the time of recommended replacement time (RRT) for previous CRT device.
  • Sinus Rhythm at the time of enrollment

排除标准

  • Moderate to severe Aortic Stenosis
  • Moderate to severe Mitral Regurgitation
  • Patient age <18 years old
  • AF burden >15%
  • Severe pulmonary disease requiring supplemental oxygen use
  • System Modification at RRT Generator Changeout
  • AdaptivCRT prior to enrollment
  • Expected patient longevity < 1 year
  • Persistant or chronic atrial fibriliation
  • Women who are pregnant or who plan to become pregnant during the clinical trial

结局指标

主要结局

Ejection fraction

时间窗: 12 Months

Change in ejection fraction as determined by echocardiography 6 months following the addition of adaptive CRT as compared to the same end points following patient management optimization

NYHA functional class

时间窗: 12 months

Change in NYHA functional class 6 months following the addition of adaptive CRT as compared to the same end points following patient management optimization

次要结局

  • Left ventricular end systolic volume(12 months)
  • Atrial fibrillation burden(12 Months)
  • Heart failure hospitalizations(12 months)
  • Time to first appropriate therapy for VT and/or VF(12 months)
  • Percentage of RV synchronized LV pacing(12 months)

研究者

发起方
Stern Cardiovascular Foundation, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Implementation of a Protocol Utilizing Adaptive CRT... | 临床试验